Lewis A Lewis X is a Tumor Associated Carbohydrate Antigen specifically expressed on the surface of squamous lung carcinoma cells. Because Carbohydrates are involved in immune response, this characteristic makes it a potential target for carbohydrate-based vaccine design. This thesis describes the synthesis of the tetra- and penta-saccharide fragments of the Lewis A Lewis X. Tetrasaccharide 1 was synthesized in an overall yield of 8% from N-acetylglucosamine acceptor 9. Both pentsaccharide framents 2 and 3 were synthesized from tetrasacharide acceptor 12 in two and three steps respectivily. These fragments will be tested for cross reactivity using competitive enzyme linked immunosorbent assay (ELISA). Positive results from the competive binding studies will pave the way for glyconjugate vaccine design against Lewis A Lewis X Tumor Associated Carbohydrate Antigen.